|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 20, 16772-16779, May 18, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Pleiotrophin (PTN) is a secreted growth factor
that induces neurite outgrowth and is mitogenic for fibroblasts,
epithelial, and endothelial cells. During tumor growth PTN can serve as
an angiogenic factor and drive tumor invasion and metastasis. To identify a receptor for PTN, we panned a phage display human cDNA library against immobilized PTN protein as a bait. From this we isolated a phage insert that was homologous to an amino acid sequence stretch in the extracellular domain (ECD) of the orphan receptor tyrosine kinase anaplastic lymphoma kinase (ALK). In parallel with PTN,
ALK is highly expressed during perinatal development of the nervous
system and down-modulated in the adult. Here we show in cell-free
assays as well as in radioligand receptor binding studies in intact
cells that PTN binds to the ALK ECD with an apparent
Kd of 32 ± 9 pM. This receptor
binding is inhibited by an excess of PTN, by the ALK ECD, and by
anti-PTN and anti-ECD antibodies. PTN added to ALK-expressing cells
induces phosphorylation of both ALK and of the downstream effector
molecules IRS-1, Shc, phospholipase C- The nucleotide sequences reported in this paper have been
submitted to the GenBankTM/EBI Data Bank with accession numbers
U66559, M57399, AF236106, and AF149800.
Identification of Anaplastic Lymphoma Kinase as a Receptor
for the Growth Factor Pleiotrophin*
§,
§,
,
,
,
,
,
, and
**
Lombardi Cancer Center, Georgetown
University, Washington, D.C. 20007, ¶ AMGEN, Thousand Oaks,
California 91320, and
Ciphergen Biosystems, 490 San Antonio
Road, Palo Alto, California 94306
, and phosphatidylinositol
3-kinase. Furthermore, the growth stimulatory effect of PTN on
different cell lines in culture coincides with the endogenous
expression of ALK mRNA, and the effect of PTN is enhanced by ALK
overexpression. From this we conclude that ALK is a receptor that
transduces PTN-mediated signals and propose that the PTN-ALK axis can
play a significant role during development and during disease processes.
*
This work was supported by National Institutes of Health
Grant CA58185 (Special Program of Research Excellence) and by a
United States Army Medical Research Materiel Command Breast
Cancer Program grant (to A. W.) as well as funds from the
Studienstiftung des Deutschen Volkes (to A. A.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
P. Landgraf, P. Wahle, H.-C. Pape, E. D. Gundelfinger, and M. R. Kreutz The Survival-promoting Peptide Y-P30 Enhances Binding of Pleiotrophin to Syndecan-2 and -3 and Supports Its Neuritogenic Activity J. Biol. Chem., September 5, 2008; 283(36): 25036 - 25045. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Duces, R. Karaky, D. Martel-Renoir, L. Mir, Y. Hamma-Kourbali, I. Bieche, P. Opolon, J. Delbe, J. Courty, M. Perricaudet, et al. 16-kDa fragment of pleiotrophin acts on endothelial and breast tumor cells and inhibits tumor development Mol. Cancer Ther., September 1, 2008; 7(9): 2817 - 2827. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. U. Magnusson, A. Dimberg, S. Mellberg, A. Lukinius, and L. Claesson-Welsh FGFR-1 regulates angiogenesis through cytokines interleukin-4 and pleiotrophin Blood, December 15, 2007; 110(13): 4214 - 4222. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, H. Wei, A. Chesley, C. Moon, M. Krawczyk, M. Volkova, B. Ziman, K. B. Margulies, M. Talan, M. T. Crow, et al. The Pro-angiogenic Cytokine Pleiotrophin Potentiates Cardiomyocyte Apoptosis through Inhibition of Endogenous AKT/PKB Activity J. Biol. Chem., November 30, 2007; 282(48): 34984 - 34993. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Amin and R. Lai Pathobiology of ALK+ anaplastic large-cell lymphoma Blood, October 1, 2007; 110(7): 2259 - 2267. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Perez-Pinera, W. Zhang, Y. Chang, J. A. Vega, and T. F. Deuel Anaplastic Lymphoma Kinase Is Activated Through the Pleiotrophin/Receptor Protein-tyrosine Phosphatase beta/{zeta} Signaling Pathway: AN ALTERNATIVE MECHANISM OF RECEPTOR TYROSINE KINASE ACTIVATION J. Biol. Chem., September 28, 2007; 282(39): 28683 - 28690. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chen, M. S. Gordon, R. A. Campbell, M. Li, C. S. Wang, H. J. Lee, E. Sanchez, S. J. Manyak, D. Gui, D. Shalitin, et al. Pleiotrophin is highly expressed by myeloma cells and promotes myeloma tumor growth Blood, July 1, 2007; 110(1): 287 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mi, W. Chen, and A. Hoke From the Cover: Pleiotrophin is a neurotrophic factor for spinal motor neurons PNAS, March 13, 2007; 104(11): 4664 - 4669. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Li, A. K. Shetty, and K. Sugahara Neuritogenic Activity of Chondroitin/Dermatan Sulfate Hybrid Chains of Embryonic Pig Brain and Their Mimicry from Shark Liver: INVOLVEMENT OF THE PLEIOTROPHIN AND HEPATOCYTE GROWTH FACTOR SIGNALING PATHWAYS J. Biol. Chem., February 2, 2007; 282(5): 2956 - 2966. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Perez-Pinera, S. Alcantara, T. Dimitrov, J. A. Vega, and T. F. Deuel Pleiotrophin disrupts calcium-dependent homophilic cell-cell adhesion and initiates an epithelial-mesenchymal transition PNAS, November 21, 2006; 103(47): 17795 - 17800. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Weng, Z. Chen, N. Jin, L. Gao, and L. Liu Gene expression profiling identifies regulatory pathways involved in the late stage of rat fetal lung development Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L1027 - L1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ichihara-Tanaka, A. Oohira, M. Rumsby, and T. Muramatsu Neuroglycan C Is a Novel Midkine Receptor Involved in Process Elongation of Oligodendroglial Precursor-like Cells J. Biol. Chem., October 13, 2006; 281(41): 30857 - 30864. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mourali, A. Benard, F. C. Lourenco, C. Monnet, C. Greenland, C. Moog-Lutz, C. Racaud-Sultan, D. Gonzalez-Dunia, M. Vigny, P. Mehlen, et al. Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage. Mol. Cell. Biol., August 1, 2006; 26(16): 6209 - 6222. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Maeda, N. Fukazawa, and T. Hata The Binding of Chondroitin Sulfate to Pleiotrophin/Heparin-binding Growth-associated Molecule Is Regulated by Chain Length and Oversulfated Structures J. Biol. Chem., February 24, 2006; 281(8): 4894 - 4902. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wan, M. S. Albom, L. Lu, M. R. Quail, N. C. Becknell, L. R. Weinberg, D. R. Reddy, B. P. Holskin, T. S. Angeles, T. L. Underiner, et al. Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells Blood, February 15, 2006; 107(4): 1617 - 1623. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Xie, E. Tassi, M. R. Swift, K. McDonnell, E. T. Bowden, S. Wang, Y. Ueda, Y. Tomita, A. T. Riegel, and A. Wellstein Identification of the Fibroblast Growth Factor (FGF)-interacting Domain in a Secreted FGF-binding Protein by Phage Display J. Biol. Chem., January 13, 2006; 281(2): 1137 - 1144. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Gouzi, C. Moog-Lutz, M. Vigny, and N. Brunet-de Carvalho Role of the subcellular localization of ALK tyrosine kinase domain in neuronal differentiation of PC12 cells J. Cell Sci., December 15, 2005; 118(24): 5811 - 5823. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bacchiocchi, G. Baldanzi, D. Carbonari, C. Capomagi, E. Colombo, W. J. van Blitterswijk, A. Graziani, and F. Fazioli Activation of {alpha}-diacylglycerol kinase is critical for the mitogenic properties of anaplastic lymphoma kinase Blood, September 15, 2005; 106(6): 2175 - 2182. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. V. Lu, K. A. Jong, G. Y. Kim, J. Singh, E. Q. Dia, K. Yoshimoto, M. Y. Wang, T. F. Cloughesy, S. F. Nelson, and P. S. Mischel Differential Induction of Glioblastoma Migration and Growth by Two Forms of Pleiotrophin J. Biol. Chem., July 22, 2005; 280(29): 26953 - 26964. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Moog-Lutz, J. Degoutin, J. Y. Gouzi, Y. Frobert, N. B.-d. Carvalho, J. Bureau, C. Creminon, and M. Vigny Activation and Inhibition of Anaplastic Lymphoma Kinase Receptor Tyrosine Kinase by Monoclonal Antibodies and Absence of Agonist Activity of Pleiotrophin J. Biol. Chem., July 15, 2005; 280(28): 26039 - 26048. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Osajima-Hakomori, I. Miyake, M. Ohira, A. Nakagawara, A. Nakagawa, and R. Sakai Biological Role of Anaplastic Lymphoma Kinase in Neuroblastoma Am. J. Pathol., July 1, 2005; 167(1): 213 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Polykratis, P. Katsoris, J. Courty, and E. Papadimitriou Characterization of Heparin Affin Regulatory Peptide Signaling in Human Endothelial Cells J. Biol. Chem., June 10, 2005; 280(23): 22454 - 22461. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A.J. Oostendorp, C. Robin, C. Steinhoff, S. Marz, R. Brauer, U. A. Nuber, E. A. Dzierzak, and C. Peschel Long-Term Maintenance of Hematopoietic Stem Cells Does Not Require Contact with Embryo-Derived Stromal Cells in Cocultures Stem Cells, June 1, 2005; 23(6): 842 - 851. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Florin, N. Maas-Szabowski, S. Werner, A. Szabowski, and P. Angel Increased keratinocyte proliferation by JUN-dependent expression of PTN and SDF-1 in fibroblasts J. Cell Sci., May 1, 2005; 118(9): 1981 - 1989. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Bao, T. Mikami, S. Yamada, A. Faissner, T. Muramatsu, and K. Sugahara Heparin-binding Growth Factor, Pleiotrophin, Mediates Neuritogenic Activity of Embryonic Pig Brain-derived Chondroitin Sulfate/Dermatan Sulfate Hybrid Chains J. Biol. Chem., March 11, 2005; 280(10): 9180 - 9191. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Muramatsu, P. Zou, H. Suzuki, Y. Oda, G.-Y. Chen, N. Sakaguchi, S. Sakuma, N. Maeda, M. Noda, Y. Takada, et al. {alpha}4{beta}1- and {alpha}6{beta}1-integrins are functional receptors for midkine, a heparin-binding growth factor J. Cell Sci., October 15, 2004; 117(22): 5405 - 5415. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Motegi, J. Fujimoto, M. Kotani, H. Sakuraba, and T. Yamamoto ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth J. Cell Sci., July 1, 2004; 117(15): 3319 - 3329. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wang, S. Oparil, J. A. Feng, P. Li, G. Perry, L. B. Chen, M. Dai, S. W.M. John, and Y.-F. Chen Effects of Pressure Overload on Extracellular Matrix Expression in the Heart of the Atrial Natriuretic Peptide-Null Mouse Hypertension, July 1, 2003; 42(1): 88 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chiarle, J. Z. Gong, I. Guasparri, A. Pesci, J. Cai, J. Liu, W. J. Simmons, G. Dhall, J. Howes, R. Piva, et al. NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors Blood, March 1, 2003; 101(5): 1919 - 1927. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shibata, T. Muramatsu, M. Hirai, T. Inui, T. Kimura, H. Saito, L. M. McCormick, G. Bu, and K. Kadomatsu Nuclear Targeting by the Growth Factor Midkine Mol. Cell. Biol., October 1, 2002; 22(19): 6788 - 6796. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Said, B. Krust, S. Nisole, J. Svab, J.-P. Briand, and A. G. Hovanessian The Anti-HIV Cytokine Midkine Binds the Cell Surface-expressed Nucleolin as a Low Affinity Receptor J. Biol. Chem., September 27, 2002; 277(40): 37492 - 37502. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Bowden, G. E. Stoica, and A. Wellstein Anti-apoptotic Signaling of Pleiotrophin through Its Receptor, Anaplastic Lymphoma Kinase J. Biol. Chem., September 20, 2002; 277(39): 35862 - 35868. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Stoica, A. Kuo, C. Powers, E. T. Bowden, E. B. Sale, A. T. Riegel, and A. Wellstein Midkine Binds to Anaplastic Lymphoma Kinase (ALK) and Acts as a Growth Factor for Different Cell Types J. Biol. Chem., September 20, 2002; 277(39): 35990 - 35998. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Bernard-Pierrot, J. Delbe, V. Rouet, M. Vigny, M.-E. Kerros, D. Caruelle, D. Raulais, D. Barritault, J. Courty, and P. E. Milhiet Dominant Negative Effectors of Heparin Affin Regulatory Peptide (HARP) Angiogenic and Transforming Activities J. Biol. Chem., August 23, 2002; 277(35): 32071 - 32077. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Piccinini, R. Bacchiocchi, M. Serresi, C. Vivani, S. Rossetti, C. Gennaretti, D. Carbonari, and F. Fazioli A Ligand-inducible Epidermal Growth Factor Receptor/Anaplastic Lymphoma Kinase Chimera Promotes Mitogenesis and Transforming Properties in 3T3 Cells J. Biol. Chem., June 14, 2002; 277(25): 22231 - 22239. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Asahina, H. Sato, C. Yamasaki, M. Kataoka, M. Shiokawa, S. Katayama, C. Tateno, and K. Yoshizato Pleiotrophin/Heparin-Binding Growth-Associated Molecule as a Mitogen of Rat Hepatocytes and Its Role in Regeneration and Development of Liver Am. J. Pathol., June 1, 2002; 160(6): 2191 - 2205. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Powers, A. Aigner, G. E. Stoica, K. McDonnell, and A. Wellstein Pleiotrophin Signaling through Anaplastic Lymphoma Kinase Is Rate-limiting for Glioblastoma Growth J. Biol. Chem., April 12, 2002; 277(16): 14153 - 14158. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takei, K. Kadomatsu, S. Matsuo, H. Itoh, K. Nakazawa, S. Kubota, and T. Muramatsu Antisense Oligodeoxynucleotide Targeted to Midkine, a Heparin-binding Growth Factor, Suppresses Tumorigenicity of Mouse Rectal Carcinoma Cells Cancer Res., December 1, 2001; 61(23): 8486 - 8491. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tassi, A. Al-Attar, A. Aigner, M. R. Swift, K. McDonnell, A. Karavanov, and A. Wellstein Enhancement of Fibroblast Growth Factor (FGF) Activity by an FGF-binding Protein J. Biol. Chem., October 19, 2001; 276(43): 40247 - 40253. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ueno, S. Yamada, M. Zako, M. Bernfield, and K. Sugahara Structural Characterization of Heparan Sulfate and Chondroitin Sulfate of Syndecan-1 Purified from Normal Murine Mammary Gland Epithelial Cells. COMMON PHOSPHORYLATION OF XYLOSE AND DIFFERENTIAL SULFATION OF GALACTOSE IN THE PROTEIN LINKAGE REGION TETRASACCHARIDE SEQUENCE J. Biol. Chem., July 27, 2001; 276(31): 29134 - 29140. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |